Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
AxoGen Reaffirms FY20 Sales Guidance Of $124M-$128M vs $131.75M Est.
12:00am, Monday, 24'th Feb 2020The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
BerganKDV Wealth Management LLC Lowers Stock Holdings in AxoGen, Inc (NASDAQ:AXGN)
09:52am, Sunday, 23'rd Feb 2020
BerganKDV Wealth Management LLC decreased its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 30.3% during the fourth quarter, HoldingsChannel reports. The firm owned 23,000 shares of the medical e
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
12:00am, Sunday, 23'rd Feb 2020Analyzing AxoGen (NASDAQ:AXGN) and TransMedics Group (NASDAQ:TMDX)
07:42am, Saturday, 22'nd Feb 2020
AxoGen (NASDAQ:AXGN) and TransMedics Group (NASDAQ:TMDX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profit
AxoGen (AXGN) to Release Quarterly Earnings on Monday
06:24am, Saturday, 22'nd Feb 2020
AxoGen (NASDAQ:AXGN) is set to announce its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. In
AxoGen, Inc (NASDAQ:AXGN) Shares Acquired by Synovus Financial Corp
06:30pm, Friday, 21'st Feb 2020
Synovus Financial Corp lifted its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 11.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &
AxoGen, Inc (NASDAQ:AXGN) Expected to Announce Earnings of -$0.08 Per Share
11:38am, Monday, 17'th Feb 2020
Equities research analysts forecast that AxoGen, Inc (NASDAQ:AXGN) will post earnings of ($0.08) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have ma
Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference
12:00pm, Wednesday, 05'th Feb 2020
ALACHUA, Fla., Feb. 05, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral.
Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference
12:00am, Wednesday, 05'th Feb 2020Axogen, Inc. to Report Fourth Quarter and Full-Year 2019 Financial Results and Host Conference Call on February 24, 2020
12:00pm, Monday, 03'rd Feb 2020
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report fourth quarter and fu
How Many AxoGen, Inc. (NASDAQ:AXGN) Shares Did Insiders Buy, In The Last Year?
10:55am, Monday, 03'rd Feb 2020
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
Analyzing AxoGen (NASDAQ:AXGN) & TransMedics Group (NASDAQ:TMDX)
08:17am, Monday, 03'rd Feb 2020
TransMedics Group (NASDAQ:TMDX) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their inst
Axogen, Inc. to Report Fourth Quarter and Full-Year —…–9 Financial Results and Host ...
12:00am, Monday, 03'rd Feb 2020What Did AxoGen, Inc.’s (NASDAQ:AXGN) CEO Take Home Last Year?
10:51am, Friday, 31'st Jan 2020
Karen Zaderej became the CEO of AxoGen, Inc. (NASDAQ:AXGN) in 2011. First, this article will compare CEO compensation...
